Definitive Cost Of Revenue from 2010 to 2024

DH Stock  USD 4.74  0.01  0.21%   
Definitive Healthcare's Cost Of Revenue is decreasing with very volatile movements from year to year. Cost Of Revenue is predicted to flatten to about 44.9 M. For the period between 2010 and 2024, Definitive Healthcare, Cost Of Revenue quarterly trend regression had mean deviation of  1,829,200 and range of 17 M. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-12-31
Previous Quarter
47.5 M
Current Value
44.9 M
Quarterly Volatility
3.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Definitive Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Definitive Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 57.6 M, Interest Expense of 16.7 M or Selling General Administrative of 35.5 M, as well as many indicators such as Price To Sales Ratio of 4.24, Dividend Yield of 0.0115 or PTB Ratio of 1.24. Definitive financial statements analysis is a perfect complement when working with Definitive Healthcare Valuation or Volatility modules.
  
Check out the analysis of Definitive Healthcare Correlation against competitors.

Latest Definitive Healthcare's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Definitive Healthcare Corp over the last few years. Cost of Revenue is found on Definitive Healthcare income statement and represents the costs associated with goods and services Definitive Healthcare provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Definitive Healthcare's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Definitive Healthcare's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Very volatile
   Cost Of Revenue   
       Timeline  

Definitive Cost Of Revenue Regression Statistics

Arithmetic Mean42,438,000
Geometric Mean42,270,264
Coefficient Of Variation8.49
Mean Deviation1,829,200
Median43,036,000
Standard Deviation3,602,409
Sample Variance13T
Range17M
R-Value(0.04)
Mean Square Error14T
R-Squared0
Significance0.89
Slope(32,504)
Total Sum of Squares181.7T

Definitive Cost Of Revenue History

202444.9 M
202347.5 M
202242.6 M
202140.7 M
202030.5 M

About Definitive Healthcare Financial Statements

Investors use fundamental indicators, such as Definitive Healthcare's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Definitive Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cost Of Revenue47.5 M44.9 M

Currently Active Assets on Macroaxis

Check out the analysis of Definitive Healthcare Correlation against competitors.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.09)
Revenue Per Share
2.187
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.01)
Return On Equity
(0.55)
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.